Skip to main content
SpringerLink
Log in

Expression of Different Extracellular Matrix Components in Human Brain Tumor and Melanoma Cells in Respect to Variant Culture Conditions

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Local tumor invasion into the surrounding brain tissue is a major characteristic of malignant gliomas. These processes critically depend on the interaction of tumor cells with various extracellular matrix (ECM) components. Because only little quantitative information about expression of ECM gene products in general and expression in response to alterations of the surrounding environment is available, the present study was designed. Four human glioblastoma cell lines (U373MG, U138MG, U251MG, GaMG) as well as four human melanoma cell lines (MV3, BLM, 530, IF6) were tested with semiquantitative RT-PCR for their ability to express mRNA of different human ECM components (fibronectin, decorin, tenascin, collagen I, collagen IV, versican). In addition, two human medulloblastoma (MHH-Med 1, MHH-Med 4) and two fibrosarcoma (HT1080, U2OS) cell lines were analyzed. Cells which were grown in DMEM medium containing 10% FCS expressed most of the analyzed protein components. When the same medium, but depleted of ECM proteins by filtrating through a membrane with cut-off at >100 kD was used, basal mRNA expression of the ECM proteins was changed in most of the examined cell lines. Using serum free conditions, most of the cell lines again showed a variation in the expression pattern of mRNA encoding for the different ECM proteins compared to the other medium conditions. Comparing different cell lines from one tumor entity or different tumor groups, ECM expression was heterogeneous with regard to the different tumor entities as well as within the entities themselves. Migration assays revealed heterogeneous responses between the different cell lines, ECM components and culture conditions, making it difficult to correlate ECM expression patterns and migratory behavior.

Our results revealed that all examined cell lines are able to produce ECM proteins in vitro. This suggests that tumor cells can modulate their microenvironment in vitro which has to be taken into consideration for studies related to migration and invasion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kreis T, Vale R (eds): Guidebook to the Extracellular Matrix and Adhesion Proteins, Oxford University Press, 1993

  2. Venstrom KA, Reichardt LF: Extracellular matrix 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 7: 996–1003, 1993

    PubMed  Google Scholar 

  3. Letourneau PC, Condic ML, Snow DM: Interactions of developing neurons with the extracellular matrix. J Neurosci 14: 915–928, 1994

    PubMed  Google Scholar 

  4. Paulus W, Tonn JC: Interactions of glioma cells and extracellular matrix. J Neuro-Oncol 24: 87–91, 1995

    Google Scholar 

  5. Goldbrunner RH, Bernstein JJ, Tonn JC: ECM-mediated glioma cell invasion. Microscopy Res Technique (in press) 1998

  6. Rutka JT, Giblin JR, Apodaca G, De Armond SJ, Stern J, Rosenblum ML: Inhibition of growth and induction of differentiation in malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins. Cancer Res 47: 3515–3522, 1987

    PubMed  Google Scholar 

  7. Rutka JT, Apodaca G, Stern R, Rosenblum M: The extracellular matrix of the central and peripheral nervous system: Structure and function. J Neurosurg: 69, 155–170, 1988

    PubMed  Google Scholar 

  8. Hynes RO: Integrins: versatility, modulation, and signalling in cell adhesion. Cell 69: 11–25, 1992

    Article  PubMed  Google Scholar 

  9. Bouterfa H, Janka M, Meese E, Kerkau, K, Roosen K, Tonn JC: Effect of changes in the CD44 gene on tumour cell invasion in glioma. Neuropath Appl Neurobiol 23: 373–379, 1997

    Google Scholar 

  10. Giese A, Rief MD, Loo MA, Berens ME: Determinants of human astrocytoma migration. Cancer Res 54: 3897–3404, 1994

    Google Scholar 

  11. Paulus W, Baur I, Schuppan D, Roggendorf W: Characterization of integrin receptors in normal and neoplatic human brain. Am J Path 143: 154–163, 1993

    PubMed  Google Scholar 

  12. Berens ME, Rief MD, Loo MA, Giese A: The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metasasis 12: 405–415, 1994

    Google Scholar 

  13. Weller RO, Koda S, Zhang ET: Pathways of fluid drainage from the brain. Morphological aspects and immunological significance in rat and man. Brain Pathol 2: 277–289, 1992

    PubMed  Google Scholar 

  14. Pedersen PH, Rucklidge GJ, Mork SJ, Terzis AJ, Engebraaten O, Lund-Johansen M, Backlund EO, Laerum OD, Bjerkvig R: Leptomeningeal tissue: a barrier against tumor cell invasion. J Natl Cancer Inst 86(21): 1593–1599, 1994

    PubMed  Google Scholar 

  15. Bernstein JJ, Goldberg WJ, Laws Jr ER: Human malignant astrocytoma xenografts migrate in rat brain: a model for central nervous system cancer research. J Neurosci Res 22: 134–144, 1989

    PubMed  Google Scholar 

  16. Bernstein JJ, Karp SM: Fetal migrating astrocytes do not intravasate since they are excluded from blood vessels by vital basement membrane. Int J Devel Neurosci 14: 177–180, 1996

    Google Scholar 

  17. Goldbrunner RH, Bernstein JJ, Vince OH, Roosen K, Tonn JC: Vascularization of human glioma spheroids implanted into rat cortex. J Neurosci Res: (submitted)

  18. Goldbrunner RH, Haugland HK, Klein CE, Kerkau S, Roosen K, Tonn JC: ECM dependent and integrin mediated tumor cell migration of human glioma and melanoma cell lines under serum free conditions. Anticancer Res 16: 3679–3688, 1996

    PubMed  Google Scholar 

  19. Bernstein JJ, Woodard CA: Glioblastoma cells do not intravasate into blood vessels. Neurosurgery 36: 124–132, 1995

    PubMed  Google Scholar 

  20. Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Ockler R, Freihoff D, Albrecht S, Wiestler OD, Zeltzer P, Riehm H: Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 54: 3278–3287, 1994

    PubMed  Google Scholar 

  21. Mahesparan R, Tysnes BB, Bjerkvig R, Lund-Johansen M, Knott J, Terzis JA, Mork S, Ness GO, Edvardsen K: Is laminin an important factor in glioma cell migration and invasion? Abstract 133, 11th International Conference on Brain Tumor Research and Therapy, Napa, Californa 1995

  22. Mahesparan R, Tysnes BB, Edvardsen K, Haugeland HK, Garcia-Cabrera I, Lund-Johansen, Engebraaten O, Bjerkvig R: Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathol Appl Neurobiol 23: 102–112, 1997

    PubMed  Google Scholar 

  23. Knott JCA, Mahesparan R, Garcia-Cabrera I, Bolge Tysnes B, Edvardsen K, Ness GO, Mork S, Lund-Johansen M, Bjerkvig R: Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int J Cancer 75: 864–872, 1998

    PubMed  Google Scholar 

  24. Paetau A: Glial fibrillary acidic protein, vimentin and fibronectin in primary cultures of human glioma and fetal brain. Acta Neuropathol 75: 448–455, 1988

    PubMed  Google Scholar 

  25. Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68: 698–704, 1988

    PubMed  Google Scholar 

  26. Bellon G, Caulet T, Cam Y, Pluot M, Poulin G, Pytlinska M, Bernard MH: Immunohistochemical localization of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas. Acta Neuropathol 66: 245–252, 1985

    PubMed  Google Scholar 

  27. McKeever PE, Varani J, Papadopoulos SM, Wang M, Mc Coy JP: Products of cells from gliomas: IX. Evidence that two fundamentally different mechanisms change extracellular matrix expression by gliomas. J Neuro-Oncol 24(3): 267–280, 1995

    Google Scholar 

  28. Paulus W, Huettner C, Tonn JC: Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroids and early monolayer cultures. Int J Cancer 58: 841–846, 1994

    PubMed  Google Scholar 

  29. Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery: 39: 235–252, 1996

    PubMed  Google Scholar 

  30. Finn PE, Bjerkvig R, Pilkington GJ: The role of growth factors in the malignant and invasive progression of intrinsic brain tumours. Anticancer Res 17(6B): 4163–4172, 1997

    PubMed  Google Scholar 

  31. Zagzag D, Friedlander DR, Dosik J, Chikramane S, Chan W, Greco MA, Allen JC, Dorovini-Zis K, Grumet M: Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 56: 182–189, 1996

    PubMed  Google Scholar 

  32. Higuchi M, Olmishi T, Arita N, Hiraga S, Hayakawa T: Expression of human tenascin in human gliomas: It's relation to histological malignancy, tumor dedifferentiation and angiogenesis, Acta Neuropathol 85: 481–487, 1993

    PubMed  Google Scholar 

  33. Enam SA, Rosenblum ML, Edvardsen K: Role of extracellular matrix in tumor invasion: migration of glioma cells along fibronectin-positive mesenchymal cell processes. Neurosurgery 42: 599–608, 1998

    PubMed  Google Scholar 

  34. Castellani P, Dorcaratto A, Siri A, Zardi L, Viale GL: Tenascin distribution in human brain tumours, Acta Neurochirurgica 136: 44–50, 1995

    PubMed  Google Scholar 

  35. Tuominen H, Kallioinen M: Increased tenascin expression in melanocytic tumors. J Cutan Pathol 21(5): 424–429, 1994

    PubMed  Google Scholar 

  36. Margolis RU, Margolis RK: Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol 245: 105–126, 1994

    PubMed  Google Scholar 

  37. Yamagata M, Saga S, Kato M, Bemfield M, Kimata K: Selective distributations of proteoglycans and their roles in pericellular matrix of cultured fibroblasts. Implication for their roles in cell substratum adhesion. J Cell Sci 106: 55–65, 1993

    PubMed  Google Scholar 

  38. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR: Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 121: 2303–2312, 1995

    PubMed  Google Scholar 

  39. Durs-Zimmermann MT, Zimmermann DR: A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 269: 32992–32998, 1994

    PubMed  Google Scholar 

  40. Ito K, Shinomura T, Zako M, Ujita M, Kimata K: Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 270: 958–965, 1995

    PubMed  Google Scholar 

  41. Paulus W, Baur I, Dours-Zimmermann T, Zimmermann D: Differential expression ofVersican isoforms in brain tumors.J Neuropathol Experiment Neurol 5(5): 528–533, 1996

    Google Scholar 

  42. Wright TN, Heinegard DK, Hascall VC: Proteoglycans: structure and function. In: Hay ED (ed) Cell Biology of the Extracellular Matrix. Plenum Press New York, 45–78, 1991

    Google Scholar 

  43. Stichel C, Kappler J, Junghans U, Koops A, Kresse H, M¨uller HW: Differential expression of small chondroitin/ dermatan sulfate proteoglycans decorin and biglycan after injury of the adult rat brain. Brain Res 704: 263–274, 1995

    PubMed  Google Scholar 

  44. Voss B, Gl¨ossl J, Cully Z, Kresse H: Immunocytochemical investigation on the distribution of small chondroitin sulfatedermatan sulfate proteoglycans in human. J Histochem Cytochem 34: 1013–1019, 1986

    PubMed  Google Scholar 

  45. St¨ander M, Naumann U, Dumitrescu L, Heneka M, L¨oschmann P, Gulbins E, Dichgans J, Weller M: Decorin gene transfer-mediated suppression of TGF-_ synthesis abrogates experimental malignant glioma growth in vivo. in press Gene Therap

  46. Pulkkinen L, Alitalo T, Krusius T, Peltonen L: Expression of decorin in human tissues and cell lines and defined chromosomal assignment of the gene locus (DCN). Cytogenet Cell Genet 60: 107–111, 1992

    PubMed  Google Scholar 

  47. Higuchi M, Ohnishi T, Arita N, Hiraga S, Iwasaki H, Hayakawa T: Immunohistochemical localization of fibronectin, laminin and fibronectin receptor in human malignant gliomas: In relation to tumor invasion. Brain Nerve 43: 17–23, 1991

    PubMed  Google Scholar 

  48. Ohnishi T, Arita N, Hiraga S, Higuchi M, Hayakawa T: Human malignant glioma cells migrate to fibronectin and laminion: Role of extracellular matrix components in glioma cell invasion. In: TabuchiK(ed): Biological Aspects of Brain Tumors pp 480–415 Tokyo, Springer-Verlag 1991

    Google Scholar 

  49. Couchman JR, Rees DA, Green MR, Smith CO: Fibronectin has a dual role in locomotion and anchorage of primary chick fibroblasts and can promote entry into the division cycle. J Cell Biol 93: 402–410, 1982

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Würzburg, Würzburg, Germany

    Hakim Bouterfa, Anne-Rose Darlapp, Klaus Roosen & Jörg C. Tonn

  2. Department of Dermatology, University of Würzburg, Würzburg, Germany

    Eberhardt Klein

  3. Department of Neuropathology, University of Bonn, Medical Center, Germany

    Torsten Pietsch

Authors
  1. Hakim Bouterfa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne-Rose Darlapp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eberhardt Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Torsten Pietsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Klaus Roosen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jörg C. Tonn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bouterfa, H., Darlapp, AR., Klein, E. et al. Expression of Different Extracellular Matrix Components in Human Brain Tumor and Melanoma Cells in Respect to Variant Culture Conditions. J Neurooncol 44, 23–33 (1999). https://doi.org/10.1023/A:1006331416283

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006331416283

Search

Navigation